US Patent Issued to Chongqing Pharmaceutical Research Institute, Yaopharma on Sept. 23 for "GLP-1R agonist compound and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,874, issued on Sept. 23, was assigned to Chongqing Pharmaceutical Research Institute Co. Ltd. (Chongqing, China) and Yaopharma Co. Ltd. (Chongqing, China).

"GLP-1R agonist compound and use thereof" was invented by Wei Nie (Chongqing, China), Xiaolong Kerri Yan (Chongqing, China), Haoying Xu (Chongqing, China), Qiang Liu (Chongqing, China), Zhichao Xu (Chongqing, China), Hongkun Qin (Chongqing, China), Xiang Li (Chongqing, China), Hongyi Liu (Chongqing, China), Yaming Cao (Chongqing, China) and Xiaoqing Bai (Chongqing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a GLP-1R agonist compound and use thereof, an...